Michael Schelleckes

Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction Versus Treatment Switch

Frank Weidemann, Johannes Krämer, Thomas Duning et al. · Journal of the American Society of Nephrology · 2014 · 68 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +13

Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene

Malte Lenders, Thomas Duning, Michael Schelleckes et al. · PLoS ONE · 2013 · 47 citations · Full text

Life Sciences, Genetics, Neurology +17

Thromboembolic events in Fabry disease and the impact of factor V Leiden

Malte Lenders, Nesrin Karabul, Thomas Duning et al. · Neurology · 2015 · 39 citations

Medicine, Clinical Sciences, Hematology +17

Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro

Boris Schmitz, Peter Vischer, Eva Brand et al. · Atherosclerosis · 2013 · 27 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A-10T genotype

Michael Schelleckes, Malte Lenders, Katrin Guske et al. · Orphanet Journal of Rare Diseases · 2014 · 24 citations · Full text

Life Sciences, Genetics, Neurology +14